Lynn A. Collyar

Lynn A. Collyar is an American oncology nurse and clinical research expert recognized for her pioneering work in patient advocacy and the strategic design of clinical trials. Her career has bridged the operational, regulatory, and patient-centric aspects of cancer research, significantly influencing how trials are conducted within community oncology settings. Collyar has held leadership roles at major research networks and healthcare institutions, advocating for greater patient access to innovative therapies.

Early life and education

Collyar completed her undergraduate studies in nursing at the University of Illinois Urbana-Champaign, laying the foundation for her clinical career. She then pursued advanced training, earning a Master of Science in Nursing from Rush University in Chicago. Her early professional experience in direct patient care within oncology units provided critical insight into the challenges faced by individuals undergoing cancer treatment, which would later shape her research advocacy focus.

Career

Collyar's career began in direct patient care, but she quickly transitioned into clinical research operations. She held significant positions at the University of Chicago's Cancer Research Center, where she managed oncology trial portfolios. She later served as the Director of Clinical Research for US Oncology, a large national network of community-based oncologists, where she was instrumental in streamlining trial processes across numerous sites. Subsequently, she joined Advocate Health Care as the Administrative Director of Oncology Research, overseeing a vast clinical research program across one of the largest integrated health systems in the Midwestern United States. She is also the President and founder of Drug Development Resources, a consultancy firm.

Research and contributions

Collyar's primary contributions lie in optimizing clinical trial design and execution to enhance patient participation and data quality. She has been a vocal advocate for incorporating the patient-reported outcome into trial endpoints, ensuring that research measures what matters most to patients. Her work with US Oncology helped demonstrate the feasibility and value of conducting large-scale Phase III clinical trials within community practices, broadening access beyond traditional academic medical centers. She has authored numerous articles and served on committees for organizations like the American Society of Clinical Oncology and the National Cancer Institute to develop best practices in clinical research.

Awards and honors

For her impactful work, Collyar has received several distinguished awards. She is a recipient of the Oncology Nursing Society's prestigious Public Service Award for her advocacy efforts. Her contributions to clinical research have also been recognized by the Coalition of Cancer Cooperative Groups with a leadership award. Furthermore, she has been invited to serve on advisory boards for the Food and Drug Administration and various pharmaceutical companies, highlighting her respected expertise in the field.

Personal life

Collyar maintains a private personal life, with available information focusing on her professional endeavors. She is known to be an active speaker at national and international conferences, including those hosted by the American Association for Cancer Research and the European Society for Medical Oncology. Her commitment extends to mentoring the next generation of clinical research coordinators and oncology nurses, emphasizing the integral role of nursing expertise in advancing cancer research.

Category:American nurses Category:American oncologists Category:Clinical researchers